161 related articles for article (PubMed ID: 34291547)
1. Dimethyl fumarate treatment for psoriasis in a real-life setting: A multicentric retrospective study.
Corazza M; Odorici G; Conti A; Di Lernia V; Motolese A; Bardazzi F; Di Nuzzo S; Monti A; Arginelli F; Filippi F; Valpiani G; Morotti C; Borghi A
Dermatol Ther; 2021 Sep; 34(5):e15066. PubMed ID: 34291547
[TBL] [Abstract][Full Text] [Related]
2. Dimethyl Fumarate: A Review in Moderate to Severe Plaque Psoriasis.
Blair HA
Drugs; 2018 Jan; 78(1):123-130. PubMed ID: 29236231
[TBL] [Abstract][Full Text] [Related]
3. Clinical use of dimethyl fumarate in moderate-to-severe plaque-type psoriasis: a European expert consensus.
Mrowietz U; Barker J; Boehncke WH; Iversen L; Kirby B; Naldi L; Reich K; Tanew A; van de Kerkhof PCM; Warren RB
J Eur Acad Dermatol Venereol; 2018 Oct; 32 Suppl 3():3-14. PubMed ID: 30238510
[TBL] [Abstract][Full Text] [Related]
4. Dimethyl fumarate (DMF) vs. monoethyl fumarate (MEF) salts for the treatment of plaque psoriasis: a review of clinical data.
Landeck L; Asadullah K; Amasuno A; Pau-Charles I; Mrowietz U
Arch Dermatol Res; 2018 Aug; 310(6):475-483. PubMed ID: 29574575
[TBL] [Abstract][Full Text] [Related]
5. A safety evaluation of dimethyl fumarate in moderate-to-severe psoriasis.
Reszke R; Szepietowski JC
Expert Opin Drug Saf; 2020 Apr; 19(4):373-380. PubMed ID: 32129112
[No Abstract] [Full Text] [Related]
6. Real-life experience with dimethylfumarate in palmoplantar psoriasis: A multicentre retrospective Italian study.
Giacomo C; Emanuele T; Martina B; Eugenio C; Federico D; Viviana L; Maria PL; Ruslana GS; Thais FM; Marco M; Elena C; Annamaria O; Aurora P; Francesca P
Australas J Dermatol; 2024 Jun; 65(4):e92-e96. PubMed ID: 38268135
[TBL] [Abstract][Full Text] [Related]
7. Use of fumaric acid esters in psoriasis.
Roll A; Reich K; Boer A
Indian J Dermatol Venereol Leprol; 2007; 73(2):133-7. PubMed ID: 17456929
[TBL] [Abstract][Full Text] [Related]
8. Switch of psoriasis therapy from a fumaric acid ester mixture to dimethyl fumarate monotherapy: Results of a prospective study.
Falkvoll S; Gerdes S; Mrowietz U
J Dtsch Dermatol Ges; 2019 Sep; 17(9):906-912. PubMed ID: 30644638
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of LAS41008 (dimethyl fumarate) in adults with moderate-to-severe chronic plaque psoriasis: a randomized, double-blind, Fumaderm
Mrowietz U; Szepietowski JC; Loewe R; van de Kerkhof P; Lamarca R; Ocker WG; Tebbs VM; Pau-Charles I
Br J Dermatol; 2017 Mar; 176(3):615-623. PubMed ID: 27515097
[TBL] [Abstract][Full Text] [Related]
10. Addition of pentoxifylline could reduce the side effects of fumaric acid esters in the treatment of psoriasis.
Friedrich M; Sterry W; Klein A; Rückert R; Döcke WD; Asadullah K
Acta Derm Venereol; 2001; 81(6):429-30. PubMed ID: 11859949
[No Abstract] [Full Text] [Related]
11. Long-term safety and effectiveness of high-dose dimethylfumarate in the treatment of moderate to severe psoriasis: a prospective single-blinded follow-up study.
Lijnen R; Otters E; Balak D; Thio B
J Dermatolog Treat; 2016; 27(1):31-6. PubMed ID: 26088405
[TBL] [Abstract][Full Text] [Related]
12. Dietary habits of psoriatic patients treated with dimethyl fumarate and drug-related side effects: results from an observational study.
Borghi A; Odorici G; Monti A; Bardazzi F; DI Lernia V; Guarneri F; Corazza M
Ital J Dermatol Venerol; 2023 Feb; 158(1):26-31. PubMed ID: 36939500
[TBL] [Abstract][Full Text] [Related]
13. Dimethyl Fumarate Treatment in Patients with Moderate-to-Severe Psoriasis: A 52-week Real-life Study.
Gnesotto L; Mioso G; Bardazzi F; Filippi F; Di Lernia V; Motolese A; Di Nuzzo S; Conti A; Arginelli F; Corazza M; Odorici G; Borghi A; Gisondi P; Naldi L; Dapavo P; Parodi A; Burlando M; Piaserico S
Acta Derm Venereol; 2023 Mar; 103():adv4526. PubMed ID: 36987538
[No Abstract] [Full Text] [Related]
14. Efficacy and safety of dimethylfumarate in elderly psoriasis patients: a multicentric Italian study.
Ricceri F; Bardazzi F; Buggiani G; Burlando M; Campione E; Corazza M; Cuccia A; Dapavo P; Filippi F; Zichichi L; Parodi A; Prignano F
J Dermatolog Treat; 2022 Jun; 33(4):2000-2003. PubMed ID: 34315343
[TBL] [Abstract][Full Text] [Related]
15. Dimethyl Fumarate's Effectiveness and Safety in Psoriasis: A Real-Life Experience During the COVID-19 Pandemic.
Esposito M; Campanati A; Giunta A; Calianno G; Bianchi L; Diotallevi F; Offidani AM; Fargnoli MC
Dermatol Ther (Heidelb); 2022 Mar; 12(3):671-681. PubMed ID: 35103934
[TBL] [Abstract][Full Text] [Related]
16. Treatment of psoriasis with fumaric acid esters: results of a prospective multicentre study. German Multicentre Study.
Mrowietz U; Christophers E; Altmeyer P
Br J Dermatol; 1998 Mar; 138(3):456-60. PubMed ID: 9580799
[TBL] [Abstract][Full Text] [Related]
17. Fumaric acid esters in the treatment of psoriasis: an Italian experience.
Carboni I; De Felice C; De Simoni I; Soda R; Chimenti S
J Dermatolog Treat; 2004 Jan; 15(1):23-6. PubMed ID: 14754645
[TBL] [Abstract][Full Text] [Related]
18. Quality of life outcomes in adults with moderate-to-severe plaque psoriasis treated with dimethylfumarate (DMF): a post hoc analysis of the BRIDGE study.
van de Kerkhof PCM; Loewe R; Mrowietz U; Falques M; Pau-Charles I; Szepietowski JC
J Eur Acad Dermatol Venereol; 2020 Jan; 34(1):119-126. PubMed ID: 31465585
[TBL] [Abstract][Full Text] [Related]
19. Improving the Gastrointestinal Tolerability of Fumaric Acid Esters: Early Findings on Gastrointestinal Events with Diroximel Fumarate in Patients with Relapsing-Remitting Multiple Sclerosis from the Phase 3, Open-Label EVOLVE-MS-1 Study.
Palte MJ; Wehr A; Tawa M; Perkin K; Leigh-Pemberton R; Hanna J; Miller C; Penner N
Adv Ther; 2019 Nov; 36(11):3154-3165. PubMed ID: 31538304
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and Safety of Dimethyl Fumarate in Patients with Moderate-to-Severe Plaque Psoriasis: Results from a 52-Week Open-Label Phase IV Clinical Trial (DIMESKIN 1).
Daudén E; de la Cueva P; Salgado-Boquete L; Llamas-Velasco M; Fonseca E; Pau-Charles I; Asensio D; Guilà M; Carrascosa JM;
Dermatol Ther (Heidelb); 2023 Jan; 13(1):329-345. PubMed ID: 36456890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
